IP Library Granted Patent US 7,341,988
Granted Patent B2
US 7,341,988 · App. 10/493,460 · Granted Mar 11, 2008

Method of treating influenza with geranyl-geranyl acetone

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,341,988
App. No.
10/493,460
Granted
Mar 11, 2008
Kind
B2
Abstract

To provide a novel preventive and/or therapeutic agent against a virus, disclosed is a preventive and/or therapeutic agent against a viral infection containing geranyl-geranyl acetone as an active ingredient. Also, disclosed are inducers for increasing the activity of an anitiviral factor and for protein kinase containing geranyl-geranyl acetone as an active ingredient. Moreover, a method for preventing and/or treating a viral infection which contains administering a patient a effective amount of an agent containing geranyl-geranyl acetone as an active ingredient.

Claims (1)

1. A method of treating an influenza virus infection, said method comprising administering to a patient an effective amount of a drug comprising geranyl-geranyl acetone as an active ingredient.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 018923/0222 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2004
From: IWASAKA, HIDEO; NOGUCHI, TAKAYUKI
To: EISAI CO., LTD.
Reel/Frame 015164/0274 →